Gyroscope Therapeutics Ltd — Form D

Gyroscope Therapeutics Ltd of STEVENAGE, HERTFORDSHIRE, X0, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-15. The offering totals $148.0M, of which $148.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2021-04-15
Form: D
Accession: 0000950103-21-005591
Industry: Biotechnology
Exemptions: 06b
Total offering: $148.0M
Amount sold: $148.0M
Investors: 10
Date of first sale: 2021-03-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-395903

Issuer

Name: Gyroscope Therapeutics Ltd
CIK: 0001832123
Entity type: Corporation
Jurisdiction: UNITED KINGDOM
Incorporated: 2016
Address: STEVENAGE BIOSCIENCE CATALYST, STEVENAGE, HERTFORDSHIRE, X0, SG1 2FX
Phone: 44 (0)1438 906770

Officers, directors & promoters (14)

Name	Role	Location
Sean Bohen	Director	STEVENAGE, HERTFORDSHIRE, X0
Ian Clark	Director	SOUTH SAN FRANCISCO, CA
Jennifer Cook	Director	PHOENIX, AZ
David Fellows	Director	STEVENAGE, HERTFORDSHIRE, X0
Renee Gala	Director	San Diego, CA
Chris Hollowood	Director	STEVENAGE, HERTFORDSHIRE, X0
Wouter Joustra	Director	STEVENAGE, HERTFORDSHIRE, X0
Maha Katabi	Director	San Francisco, CA
Khurem Farooq	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0
Jane Hughes	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0
Edward Lang	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0
Ian Pitfield	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0
Jessica Stitt	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0
Nadia Waheed	Executive Officer	STEVENAGE, HERTFORDSHIRE, X0

More